![Francois Maisonrouge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francois Maisonrouge
Presidente presso Pasteur Foundation
Profilo
Francois Maisonrouge is currently the Chairman of Pasteur Foundation and a Director at Équilibre BioPharmaceuticals Corp.
He previously worked as the Chairman & Managing Director at Credit Suisse Securities (USA) LLC and as a Senior Managing Director at Evercore, Inc. Maisonrouge holds an MBA from Harvard University and a graduate degree from Ecole Centrale Lyon.
Posizioni attive di Francois Maisonrouge
Società | Posizione | Inizio |
---|---|---|
Équilibre BioPharmaceuticals Corp.
![]() Équilibre BioPharmaceuticals Corp. BiotechnologyHealth Technology Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach. | Direttore/Membro del Consiglio | - |
Pasteur Foundation
![]() Pasteur Foundation Miscellaneous Commercial ServicesCommercial Services Pasteur Foundation operates as a research center. The private company is based in New York, NY. | Presidente | - |
Precedenti posizioni note di Francois Maisonrouge
Società | Posizione | Fine |
---|---|---|
Credit Suisse Securities (USA) LLC (Broker)
![]() Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Presidente | - |
EVERCORE INC. | Corporate Officer/Principal | - |
Formazione di Francois Maisonrouge
Ecole Centrale Lyon | Graduate Degree |
Harvard University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
EVERCORE INC. | Finance |
Aziende private | 3 |
---|---|
Credit Suisse Securities (USA) LLC (Broker)
![]() Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
Équilibre BioPharmaceuticals Corp.
![]() Équilibre BioPharmaceuticals Corp. BiotechnologyHealth Technology Équilibre BioPharmaceuticals Corp. is an innovative biopharmaceutical company based in New York, NY. The company focuses on identifying and developing high-potential drugs for patients who are treatment resistant or unresponsive to other existing medications. The company's approach is to leverage their biopharmaceutical industry expertise to further expand their portfolio of product opportunities. The company is a patient-focused and science-minded company determined to have best and first-in-class therapeutics. The CEO of the company is Philip Barach. | Health Technology |
Pasteur Foundation
![]() Pasteur Foundation Miscellaneous Commercial ServicesCommercial Services Pasteur Foundation operates as a research center. The private company is based in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Francois Maisonrouge